Indeed, the modulation of vasculo-protective KLF2 may provide both, an interesting prognostic to either monitor the impact of inflammation and vascular health in advanced CKD/ESRD patients, but also an interesting therapeutic target to restore vascular health and integrity in uremic patients within vascular crisis. This evidence concerns the gene KLF2 and chronic kidney disease.